A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults
A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults
Active, not recruiting · NCT06803342 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults | Ebola Sudan Virus Disease | Active, not recruiting | Phase 2 | 2026-02-10 | NCT06803342 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Albert B. Sabin Vaccine Institute | 3 |
| Biomedical Advanced Research and Development Authority | 27 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Optimal Research; LLC | Melbourne | United States | 2 |
| Synexus Clinical Research US, Inc. | San Antonio | United States | 3 |
| Synexus Clinical Research US, Inc. | Phoenix | United States | 8 |
| Synexus Clinical Research US, Inc. | Chicago | United States | 3 |